Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
2 clinical trials · Condition
◉ Watch Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer (NCT06385873) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study (NCT06091423) | Xiaofeng Chen | 2023-10-25 |
Track Gastric Cancer/Gastroesophageal Junction Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.